XML 21 R8.htm IDEA: XBRL DOCUMENT v3.3.1.900
Consolidated Statements Of Cash Flows - USD ($)
 12 Months Ended
Dec. 31, 2015
Dec. 31, 2014
Dec. 31, 2013
Operating Activities      
Net income $ 12,549,053 $ 9,672,498 $ 14,796,738
Adjustments to reconcile net income to net cash provided by (used in) operating activities:      
Depreciation 1,105,839 833,104 669,727
Amortization, net 728,510 630,782 507,111
Amortization related to postretirement benefits obligation 7,904 2,217 4,765
Share-based compensation expense related to stock options 137,762 120,891 83,852
Net (gain) loss on disposals of property (24,867) 24,608 7,831
Net realized loss (gain) on investments 116,163 (268,294) (195,800)
Net earnings from other investments (2,002,276) (1,450,980) (1,257,266)
Provision (benefit) for claims 4,478,494 5,229,716 (571,596)
Provision for deferred income taxes 1,015,000 611,000 1,804,000
Changes in assets and liabilities:      
Decrease in receivables 217,594 206,041 2,287,489
Increase in other assets (4,879,418) (393,359) (2,906,224)
Decrease (increase) in current income taxes recoverable 0 366,772 (366,772)
Increase (decrease) in accounts payable and accrued liabilities 6,689,204 (2,080,492) 4,923,858
Increase (decrease) in current income taxes payable 118,163 92,192 (1,336,824)
Payments of claims, net of recoveries 3,367,494 3,912,716 3,146,404
Net cash provided by (used in) operating activities 16,889,631 9,683,980 15,304,485
Investing Activities      
Purchases of available-for-sale securities (20,164,353) (30,899,452) (23,466,037)
Purchases of short-term securities (4,593,240) (911,188) (2,638,908)
Purchases of other investments (3,717,978) (1,689,950) (1,369,210)
Investment in/purchase of subsidiary (72,600) 0 0
Proceeds from sales and maturities of available-for-sale securities 22,151,408 12,472,817 9,892,634
Proceeds from sales and maturities of short-term securities 304,827 6,260,568 8,280,183
Proceeds from sales and distributions of other investments 3,911,286 1,584,337 2,107,675
Proceeds from sales of other assets 149,128 38,052 40,366
Purchase of redeemable noncontrolling interest of subsidiary 0 (515,275) 0
Purchases of property, equipment and software (2,742,619) (2,017,379) (1,424,108)
Proceeds from disposals of property 75,060 24,400 24,335
Net cash provided by (used in) investing activities (4,699,081) (15,653,070) (8,553,070)
Financing Activities      
Repurchases of common stock (5,483,953) (1,055,765) (4,262,260)
Exercise of options 54,988 27,100 75,797
Distribution to noncontrolling interest 0 (168,057) (36,900)
Subsidiary return of capital (35,000) 0 0
Excess tax benefits related to exercise of stock options and SARs 26,875 15,999 946,605
Dividends paid (789,907) (650,433) (657,914)
Net cash provided by (used in) financing activities (6,226,997) (1,831,156) (3,934,672)
Net Increase (Decrease) in Cash and Cash Equivalents 5,963,553 (7,800,246) 2,816,743
Cash and Cash Equivalents, Beginning of Period 15,826,515 23,626,761 20,810,018
Cash and Cash Equivalents, End of Period 21,790,068 15,826,515 23,626,761
Cash Paid During the Year for:      
Income tax payments, net 4,658,000 2,744,100 5,724,000
Non cash net unrealized loss (gain) on investments, net of deferred tax benefit (provision) of $708,564, $(805,779) and $(1,288,951) for 2015, 2014 and 2013, respectively 1,336,756 (1,538,740) (2,474,873)
Adjustments to postretirement benefits obligation, net of deferred tax benefit (provision) of $21,612, $16,021 and $(26,252) for 2015, 2014 and 2013, respectively $ 41,954 $ 31,100 $ (50,961)